Abstract:Plasma proteins may often serve as indicators of disease and are a rich source for biomarker discovery. However, the intrinsic large dynamic range of plasma proteins makes the analysis very challenging because a large number of low abundance proteins are often masked by a few high abundance proteins. The use of prefractionation methods, such as depletion of higher abundance proteins before protein profiling, can assist in the discovery and detection of less abundant proteins that may ultimately prove to be informative biomarkers. But there are few studies on comprehensive investigation of the proteins both in the fractions depleted and remainder. In the present study, two different immunoaffinity fractionation columns for the top-6 or the top-12 proteins in plasma were investigated and both the proteins in column-bound and flow-through fractions were subsequently analyzed. A two-dimensional peptide separation strategy, utilizing chromatographic separation techniques, combined with tandem mass spectrometry (MS/MS) was employed for proteomic analysis of the four fractions. Using the established HUPO PPP criteria, a total of 2401 unique plasma proteins were identified. The Multiple Affinity Removal System yielded 921 and 725 unique proteins from the flow-through and bound fractions, respectively, whereas the Seppro MIXED 12 column yielded identification of 897 and 730 unique proteins from the flow-through and bound fractions, respectively. When more stringent criteria, based on searching against the reversed database, were implemented, 529 unique proteins were identified from the four fractions with the confidence in peptide identification increased from 73.6% to 99%. To determine whether the presence of nontarget proteins in the immunoaffinity-bound fraction could be attributed to their interaction with high abundance proteins, co-immunoprecipitation analysis with an antibody to human plasma albumin was performed, which resulted in an identification of 40 unique proteins from the coimmunoprecipitate with the more stringent criteria. This study illustrated that combining the column- bound and flow-through fractions from immunoaffinity separation affords more extensive profiling of the protein content of human plasma. The presence of nontarget proteins in the column-bound fractions may be induced by their binding to the higher abundance proteins targeted by the immunoaffinity column.

Characterization of plasma protein binding dissociation with online SPE-HPLC

High-Throughput Process Development for Recombinant Human Serum Albumin Separation from Pichia Pastoris Broth with Mixed-Mode Chromatography

Protein binding study of acid drug N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine in human plasma albumin solution by high performance capillaryelectrophoresis frontal analysis

Affinity separation and enrichment methods in proteomic analysis.

The state-of-the-art machine learning model for Plasma Protein Binding Prediction: computational modeling with OCHEM and experimental validation

A Novel Strategy for Prediction of Human Plasma Protein Binding Using Machine Learning Techniques

Stereoselective protein binding studies of 2-(2-hydroxypropanamido) benzoic acid enantiomers in rat, beagle dog and human plasma

In Silico Prediction of Compounds Binding to Human Plasma Proteins by QSAR Models

Simultaneous determination of a broad range of cardiovascular drugs in plasma with a simple and efficient extraction/clean up procedure and chromatography-mass spectrometry analysis

Developing A Strong Anion Exchange/Rp (sax/rp) 2d Lc System for High-Abundance Proteins Depletion in Human Plasma

Testing for drug-human serum albumin binding using fluorescent probes and other methods

Detection of heterogeneous drug-protein binding by frontal analysis and high-performance affinity chromatography

Protein Binding Affinity of Polymeric Nanoparticles as a Direct Indicator of Their Pharmacokinetics

Semi-automated determination of plasma stability of drug discovery compounds using liquid chromatography-tandem mass spectrometry.

Simultaneous Determination Of Twenty-Five Compounds In Rat Plasma Using Ultra-High Performance Liquid Chromatography-Polarity Switching Tandem Mass Spectrometry And Its Application To A Pharmacokinetic Study

Different immunoaffinity fractionation strategies to characterize the human plasma proteome.

An Automated On-Line-SPE-HPLC Method for the Direct Pharmacokinetic Studies on Rat Plasma Samples of 3 '-Azido Analogue of Doxorubicin

Simultaneously enantiospecific determination of (+)-trans-khellactone, (+/-)-praeruptorin A, (+/-)-praeruptorin B, (+)-praeruptorin E, and their metabolites, (+/-)-cis-khellactone, in rat plasma using online solid phase extraction-chiral LC-MS/MS.

A Proteomic Approach for Plasma Biomarker Discovery with 8-Plex Itraq Labeling and SCX-LC-MS/MS

Characterization of Critical Reagents in Ligand-Binding Assays: Enabling Robust Bioanalytical Methods and Lifecycle Management

Automated kapok fiber-based pipette-tip solid-phase extraction coupled with liquid chromatography-tandem mass spectrometry for rapid and sensitive analysis of tyrosine kinase inhibitors in plasma